Laura Soucek

Laura Soucek is a researcher in the Department of Biochemistry and Molecular Biology with a significant research focus on MYC oncogene inhibition and cancer therapeutics. She maintains an active research program with 27 publications spanning from 2013 to 2024, demonstrating sustained scholarly productivity in her field.

Her research interests center on molecular oncology, particularly targeting the MYC oncogene using Omomyc as an inhibitor. Her work spans multiple cancer types including melanoma, lymphoma, and KRAS-driven cancers. Dr. Soucek's research has significant translational potential, with studies examining pharmacokinetics of Omomyc in tumor tissue and exploring prognostic gene signatures in melanoma.

Analysis of her recent publications reveals a strong focus on understanding MYC's role in cancer progression and developing targeted therapeutic approaches. Her work bridges basic molecular mechanisms with clinical applications, particularly in understanding how MYC inhibition can be leveraged for cancer treatment across various tumor types.

Dr. Soucek's research has garnered notable attention, with publications being referenced in patents, covered by multiple news outlets, and discussed across social media platforms including X (formerly Twitter) and Bluesky. Her work has also been incorporated into Wikipedia pages, indicating broader scientific impact.

She has supervised at least 3 students according to the 'Supervised work (3)' mention in her profile, contributing to the training of next-generation cancer researchers. Her research has attracted significant readership on academic platforms like Mendeley, with some publications reaching over 60 readers.